AnaCardio is a Sweden-based clinical-stage biopharmaceutical company that develops and commercializes novel drugs for the treatment of heart failure.
Business Model:
Revenue: $2.3M
Employees: 11-50
Address: Nanna Svartz vag 4
City: Solna
State: stockholms län
Zip: 171 65
Country: SE
AnaCardio is a Sweden-based clinical-stage biopharmaceutical company that develops and commercializes novel drugs for the treatment of heart failure.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2022 | Series A | $14.2M |
Flerie Invest Industrifonden Karolinska Development AB |
2/2022 | Debt | $3.6M |
Karolinska Development |
6/2021 | Seed | - | 6/2021 | Seed Round | 1 | - |
Karolinska Karolinska |
2/2022 | Debt Financing | 4 | $3.6M |
AnnHelene Ljungström Fredrik Ljungström Karolinska Nybohov Invest AnnHelene Ljungström Fredrik Ljungström Karolinska Nybohov Invest |
9/2022 | Series A | $0 |
3B Ventures Flerie Invest Industrifonden 3B Ventures Flerie Invest Industrifonden |
6/2021 | Seed | - |
Karolinska Development AB Karolinska Development AB |
9/2022 | Series A | 3 | $14M |
3B Ventures Flerie Invest Industrifonden 3B Ventures Flerie Invest Industrifonden |
6/2021 | Seed Round | 1 | - |
Karolinska Karolinska |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|